↓ Skip to main content

Chronic rhinosinusitis: an update on current pharmacotherapy

Overview of attention for article published in Expert Opinion on Pharmacotherapy, September 2013
Altmetric Badge

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chronic rhinosinusitis: an update on current pharmacotherapy
Published in
Expert Opinion on Pharmacotherapy, September 2013
DOI 10.1517/14656566.2013.837450
Pubmed ID
Authors

Gwijde FJPM Adriaensen, Wytske J Fokkens

Abstract

Chronic rhinosinusitis (CRS) is an inflammatory disease of the nasal and paranasal mucosa with great impact on quality of life and a large financial burden on society. This article provides an overview of its current and future pharmacotherapy, the mainstay of CRS treatment.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Unknown 47 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 19%
Student > Ph. D. Student 6 13%
Student > Postgraduate 5 10%
Student > Master 5 10%
Student > Bachelor 4 8%
Other 8 17%
Unknown 11 23%
Readers by discipline Count As %
Medicine and Dentistry 22 46%
Agricultural and Biological Sciences 5 10%
Nursing and Health Professions 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Immunology and Microbiology 1 2%
Other 1 2%
Unknown 15 31%